Chemical Compound

Elisidepsin

CAS Registry Number 681272-30-0
Back to search Request a Quote
Elisidepsin chemical structure
Primary Record

Elisidepsin

In stock
2,285 g
Purity
99.7 %
CAS
681272-30-0

Compound Identifiers & Properties

CAS
681272-30-0
PubChem CID
9855343
SMILES
CC[C@H](C)CCC(=O)N[C@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]2[C@H](OC(=O)[C@@H](NC(=O)/C(=C/C)/NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC2=O)[C@@H](C)CC)C(C)C)CC3=CC=CC=C3)C(C)C)C
Canonical SMILES
C/C=C1\NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CCCN)NC(=O)[C@H]2CCCN2C(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CC[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)OC(=O)[C@H](C(C)C)NC1=O

Names & Synonyms

  • Elisidepsin
  • Irvalec
  • Elisidepsin [INN]
  • elisidepsina
  • elisidepsine
  • elisidepsinum
  • ISOKAHALALIDE F
  • UNII-0FWR494EC9
  • 0FWR494EC9
  • Depsipeptide PM02734
  • ELISIDEPSIN [MI]
  • RefChem:136517
  • D08GIM
  • Elisidepsin trifluoroacetate
  • ELISIDEPSIN [WHO-DD]
  • CHEBI:83152
  • DTXSID501026290
  • orb1942287
  • SCHEMBL12942464
  • DTXCID601516242
  • 681272-30-0
  • PM-02734
  • CID9855343
  • CID 9855343
  • DA-73064
  • HY-13621
  • Kahalalide therapy (solid tumor), PharmaMar
  • CS-0007487
  • Q27156668
  • 1-[N-[(4S)-4-methyl-1-oxohexyl]-D-valine]kahalalide F
  • (2R)-N-[(2S)-5-amino-1-[[(2R,3S)-1-[[(3S,6Z,9S,12R,15R,18R,19R)-9-benzyl-15-[(2S)-butan-2-yl]-6-ethylidene-19-methyl-2,5,8,11,14,17-hexaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]-1-[(2R)-2-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2R)-3-methyl-2-[[(4S)-4-methylhexanoyl]amino]butanoyl]amino]butanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carboxamide
  • 13,8-Anhydro(N-((4S)-4-Methylhexanoyl)-D-valyl-L-threonyl-L-valyl-D-valyl-D-prolyl-L-ornithyl-D-alloisoleucyl-D-allothreonyl-D-alloisoleucyl-D-valyl-L-phenylalanyl-(2Z)-2-aminobut-2-enoyl-L-valine)
  • Erbb3 tyrosine kinase receptor inhibitor (cancer), PharmaMar
  • 1-(N-((4S)-4-METHYL-1-OXOHEXYL)-D-VALINE)KAHALALIDE F
  • (2R)-N-((2S)-5-amino-1-(((2R,3S)-1-(((3S,6Z,9S,12R,15R,18R,19R)-9-benzyl-15-((2S)-butan-2-yl)-6-ethylidene-19-methyl-2,5,8,11,14,17-hexaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)-1-((2R)-2-(((2S)-2-(((2S,3R)-3-hydroxy-2-(((2R)-3-methyl-2-(((4S)-4-methylhexanoyl)amino)butanoyl)amino)butanoyl)amino)-3-methylbutanoyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxamide
  • (R)-N-((S)-5-Amino-1-(((2R,3S)-1-(((3S,9S,12R,15R,18R,19R,Z)-9-benzyl-15-((S)-sec-butyl)-6-ethylidene-3,12-diisopropyl-19-methyl-2,5,8,11,14,17-hexaoxo-1-oxa-4,7,10,13,16-pentaazacyclononadecan-18-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)-1-((2R,5S,8S,11R,16S)-8-((R)-1-hydroxyethyl)-2,5,11-triisopropyl-16-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecan-1-oyl)pyrrolidine-2-carboxamide
  • L-VALINE, N-((4S)-4-METHYL-1-OXOHEXYL)-D-VALYL-L-THREONYL-L-VALYL-D-VALYL-D-PROLYL-L-ORNITHYL-D-ALLOISOLEUCYL-D-ALLOTHREONYL-D-ALLOISOLEUCYL-D-VALYL-L-PHENYLALANYL-(2Z)-2-AMINO-2-BUTENOYL-, (13-8)-LACTONE
  • L-Valine, N-((4S)-4-methyl-1-oxohexyl)-D-valyl-L-threonyl-L-valyl-D-valyl-D-prolyl-L-ornithyl-D-alloisoleucyl-D-allothreonyl-D-alloisoleucyl-D-valyl-L-phenylalanyl-(2Z)-2-amino-2-butenoyl-, (13-8)-lactone, 2,2,2-trifluoroacetate (1:1)
  • N-((4S)-4-METHYL-1-OXOHEXYL)-D-VALYL-L-THREONYL-L-VALYL-D-VALYL-D-PROLYL-L-ORNITHYL-D-ALLOISOLEUCYL-D-ALLOTHREONYL-D-ALLOISOLEUCYL-D-VALYL-L-PHENYLALANYL-(2Z)-2-AMINO-2-BUTENONYL-L-VALINE (13->8)-LACTONE
  • N-[(4S)-4-methyl-1-oxohexyl]-D-valyl-L-threonyl-L-valyl-D-valyl-D-prolyl-L-ornithyl-D-alloisoleucyl-D-allothreonyl-D-alloisoleucyl-D-valyl-L-phenylalanyl-(2Z)-2-amino-2-butenonyl-L-valine (13?8)-lactone
  • N-[(4S)-4-methylhexanoyl]-D-valyl-L-threonyl-L-valyl-D-valyl-D-prolyl-L-ornithyl-N-{(3S,6Z,9S,12R,15R,18R,19R)-9-benzyl-15-[(2S)-butan-2-yl]-6-ethylidene-3,12-diisopropyl-19-methyl-2,5,8,11,14,17-hexaoxo-1-oxa-4,7,10,13,16-pentaazacyclononadecan-18-yl}-D-alloisoleucinamide